The link below is an update on the biotechnology market we thought you may find of interest. Total U.S. capital raised by biotechnology companies in 2010 rose by 15% and the sector is poised for continued growth through 2011 and beyond.
Below are a few highlights touched upon in greater detail within the report:
– In the past two years there has been a significant increase in United States biotech financing
– European optimism about the prospects of the biotech industry, amid the recent market challenges, remains strong
– Over the past couple years, venture capital funds with charters that permit investments in public entities had been taking advantage of buying opportunities
– While the continued recovery of the economy may open the window for more IPOs, the rest of 2011 is expected to see more bolt-on acquisitions and bite-sized deals
Please let us know if you have questions or would like to discuss any corporate strategy or business development initiatives. We look forward to connecting soon and a productive second half of 2011.
Bourne Partners Team